Graf Akcie VYGR (Voyager Therapeutics Inc). Diskuze k akciím VYGR. Aktuální informace VYGR.

Základní informace o společnosti Voyager Therapeutics Inc (Akcie VYGR)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 154.69M
Hodnota podniku (EV) -28.79
Tržby 132.238M
EBITDA 11.132M
Zisk 17.916M
Růst v tržbách Q/Q -95.27 %
Růst v tržbách Y/Y 32.43 %
P/E (Cena vůči ziskům) 8.37
Forward P/E 0.03
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 1.17
P/FCF N/A
Price/Book 1.00
Účetní hodnota na akcii 4.09
Hotovost na akcii 4.80
FCF vůči ceně -64.67 %
Počet zaměstnanců 177
Tržba na zaměstnance 747.107k
Profit margin 21.47 %
Operating margin 5.01 %
Gross margin 100.00 %
EBIT margin 13.55 %
EBITDA margin 8.42 %
EPS - Zisk na akcii 0.49
EPS - Kvartální růst 247.83 %
EPS - Očekávaný růst příští rok -131.28 %
Return on assets 7.33 %
Return on equity 12.63 %
ROIC 11.92 %
ROCE 9.73 %
Dluhy/Equity 0.70
Čistý dluh/EBITDA -61.59
Current ratio 6.02
Quick Ratio 6.02
Volatilita 11.07
Beta 1.19
RSI 56.59
Cílová cena analytiků 15
Známka akcie (dle analytiků) 1.92
Insider ownership 14.07 %
Institutional ownership 74.93 %
Počet akcií 37.936M
Procento shortovaných akcií 3.31 %
Short ratio 4.20 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie VYGR

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$171.128$104.391$7.619$10.135$14.22$17.334--
Cost Of Goods Sold--------
Gross Profit$171.128$104.391$7.619$10.135$14.22$17.334--
Research And Development Expenses$108.753$119.735$64.905$62.26$42.249$27.679$8.898$2.316
SG&A Expenses$34.991$36.335$33.809$19.738$13.27$9.909$5.469$1.45
Other Operating Income Or Expenses--------
Operating Expenses$143.744$156.07$98.714$81.998$55.519$37.588$14.367$3.766
Operating Income$27.384$-51.679$-91.095$-71.863$-41.299$-20.254$-14.367$-3.766
Total Non-Operating Income/Expense$9.357$8.082$2.627$1.165$1.158$-9.418$-1.95$-0.067
Pre-Tax Income$36.741$-43.597$-88.468$-70.698$-40.141$-29.672$-16.317$-3.833
Income Taxes--$-0.18-$0.052---
Income After Taxes$36.741$-43.597$-88.288$-70.698$-40.193$-29.672$-16.317$-3.833
Other Income--------
Income From Continuous Operations$36.741$-43.597$-88.288$-70.698$-40.193$-29.672$-16.317$-3.833
Income From Discontinued Operations--------
Net Income$36.741$-43.597$-88.288$-70.698$-40.193$-38.29$-17.683$-3.833
EBITDA$31.228$-52.498$-91.141$-70.292$-39.991$-19.202$-14.183$-3.766
EBIT$27.384$-51.679$-91.095$-71.863$-41.299$-20.254$-14.367$-3.766
Basic Shares Outstanding3736322725410
Shares Outstanding3736322725410
Basic EPS$0.99$-1.21$-2.75$-2.64$-1.59$-9.14$-27.83$-1629.68
EPS - Earnings Per Share$0.98$-1.21$-2.75$-2.64$-1.59$-9.14$-27.83$-1629.68
# 2020 2019 2018 2017 2016 2015
Current Ratio7.38884.0085.1310.806412.95368.1858
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin100100100100100100
Operating Margin16.0021-49.5052-1195.629-709.0577-290.429-116.8455
EBIT Margin16.0021-49.5052-1195.629-709.0577-290.429-116.8455
EBITDA Margin18.2483-50.2898-1196.233-693.557-281.2307-110.7765
Pre-Tax Profit Margin21.4699-41.7632-1161.15-697.5629-282.2855-171.178
Net Profit Margin21.4699-41.7632-1158.787-697.5629-282.6512-220.8954
Asset Turnover0.65420.29430.0430.05490.0750.0755
Inventory Turnover Ratio------
Receiveable Turnover21.3595.644----
Days Sales In Receivables17.088864.6707----
ROE - Return On Equity23.8083-43.8108-190.0874-52.7396-29.5706-17.5497
Return On Tangible Equity23.8083-43.8108-190.0874-52.7396-29.5706-17.5497
ROA - Return On Assets14.0456-12.2892-49.8721-38.3235-21.2026-12.9314
ROI - Return On Investment23.8083-43.8108-190.0874-52.7396-29.5706-17.5497
Book Value Per Share4.12972.69941.43514.24595.30996.7817
Operating Cash Flow Per Share-3.94521.85111.7934-0.6098-11.532728.609
Free Cash Flow Per Share-4.05891.77521.8078-0.5597-11.485833.0655